Biomedicine has produced and is generating massive amounts of data. The open source and use of this data will be of great value. The first Open Science Prize is working to find good ideas for developing and using this data. Since its launch in October last year, the award has received participation from 96 teams from 45 countries. The panel of experts announced a list of six finalists, from simulating the fly of the fruit fly, visualizing the spread of the virus, to creating a rare disease gene pool, let us see how these finalists are playing biological big data.
About the Open Science Award
Biomedical research has produced massive amounts of data. Many of the "IEEE Overview" (IEEE Spectrum is a magazine published by the Institute of Electrical and Electronics Engineers, the flagship publication of the Institute of Electrical and Electronics Engineers, which is dedicated to exploring the development and application of cutting-edge technology). Sensors, robots, and other related technologies produce data from terabytes (terabytes, 240 bytes) to petabytes (petabytes), which are only worldwide. A negligible portion of the health information capacity stored within.
Today, three investment institutions are working to stimulate the development of tools and platforms to improve the ability of researchers to access and use this data. At the 7th Medical Data Symposium in Washington, DC, the National Institute of Health (NIH), the Wellcome Trust in the UK, and the Howard Hughes Medical Institute (Howard Hughes Medical Institute) announced the list of six finalists for the first Open Science Prize.
Part of the problem with developing these types of tools is that no one knows who is responsible for them. (Philippines Bourne, deputy director of data science at the National Institutes of Health, said: "Data generation is global, but data is essentially managed and funded by the state.
After the release in October last year, 96 teams from 45 countries participated in the competition. Yesterday, the panel announced six finalists, who will receive $80,000 in funding and continue to develop their prototypes over the next six months.
Ok, let's not say more, let's see how these teams entering the finals are playing biometric big data.
MyGene2
Rare diseases are not as rare as you might think. Today, there are more than 6,000 known rare diseases in the United States that occur in approximately 25 million people. However, more than half of the households have undergone genetic testing and cannot be diagnosed as suspected rare diseases. A website called MyGene2 (https://) brings a place for families and clinicians to share health and genetic information about rare diseases to promote detection and discovery of disease-causing New rare conditions and genes.
The family information database for each (suspected) rare disease covers the story-health information-gene data-contact information. Among them, the story part includes photos, basic patient conditions, and a true story of flesh and blood. Taking the family of 96 as an example, the author vividly described the whole process of the illness and diagnosis of his daughter Ava.
Galacto-Oligosaccharide 70% Powder
Galacto Oligosaccharides Supplement,Galacto Oligosaccharides Foods,Galacto-Oligosaccharide Food Grade Sweetener
Shandong Bailong Chuangyuan Bio-tech Co.,Ltd. Qingdao Branch , https://www.qdblcycn.com